{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:22:48Z","timestamp":1773696168424,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1053\/j.ajkd.2014.01.426","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T13:30:35Z","timestamp":1394026235000},"page":"1072-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Spironolactone to Prevent Peritoneal Fibrosis in Peritoneal Dialysis Patients: A Randomized Controlled Trial"],"prefix":"10.1053","volume":"63","author":[{"given":"Armando","family":"Vazquez-Rangel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgilia","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Escalona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael G.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar A.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser Abdel","family":"Polanco Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Falcon-Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1053\/j.ajkd.2014.01.426_bib1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/089686080002004S02","article-title":"Evaluation and management of ultrafiltration\u00a0problems in peritoneal dialysis. International Society for Peritoneal\u00a0Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis","volume":"20","author":"Mujais","year":"2000","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1053\/j.ajkd.2014.01.426_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1990.231","article-title":"Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity","volume":"38","author":"Heimburger","year":"1990","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.01.426_bib3","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1046\/j.1523-1755.2003.08805.x","article-title":"The natural course of peritoneal membrane biology during peritoneal dialysis","volume":"88","author":"Williams","year":"2003","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2014.01.426_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/089686080702700410","article-title":"The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats","volume":"27","author":"Ersoy","year":"2007","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ajkd.2014.01.426_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/089686080502500110","article-title":"Angiotensin II mediates high\u00a0glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species","volume":"25","author":"Noh","year":"2005","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1053\/j.ajkd.2014.01.426_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1523-1755.2005.00179.x","article-title":"Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1\/2 and p38 MAPK","volume":"67","author":"Kiribayashi","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2014.01.426_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/cs0750411","article-title":"Increased levels of immunoreactive plasma renin substrate during infectious peritonitis in patients on continuous ambulatory peritoneal dialysis","volume":"75","author":"Metsarinne","year":"1988","journal-title":"Clin Sci (Lond)"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614005204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614005204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:17:55Z","timestamp":1759457875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638614005204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0272638614005204"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.01.426","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone to Prevent Peritoneal Fibrosis in Peritoneal Dialysis Patients: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.01.426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}